These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26992329)

  • 1. Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips.
    Butvilovskaya VI; Popletaeva SB; Chechetkin VR; Zubtsova ZI; Tsybulskaya MV; Samokhina LO; Vinnitskii LI; Ragimov AA; Pozharitskaya EI; Grigor Eva GA; Meshalkina NY; Golysheva SV; Shilova NV; Bovin NV; Zasedatelev AS; Rubina AY
    Cancer Med; 2016 Jul; 5(7):1361-72. PubMed ID: 26992329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoassay of nine serological tumor markers on hydrogel-based microchip].
    Zubcova ZhI; Savvateeva EN; Butvilovskaia VI; Cybul'skaia MV; Chechetkin VR; Samokhina LO; Vinnitskiĭ LI; Maslennikov VV; Reznikov IuP; Zasedatelev AS; Rubina AIu
    Bioorg Khim; 2013; 39(6):693-704. PubMed ID: 25696931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
    PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients.
    Kim SB; Fernandes LC; Saad SS; Matos D
    Int J Biol Markers; 2003; 18(3):182-7. PubMed ID: 14535588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Anti-Glycan IgG and IgM Antibodies in Colorectal Cancer.
    Tikhonov AA; Savvateeva EN; Chernichenko MA; Maslennikov VV; Sidorov DV; Rubina AY; Kushlinskii NE
    Bull Exp Biol Med; 2019 Feb; 166(4):489-493. PubMed ID: 30788741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
    Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
    Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating CEA-IgM complexes in early stage colorectal cancer.
    Castaldi F; Marino M; Beneduce L; Belluco C; De Marchi F; Mammano E; Nitti D; Lise M; Fassina G
    Int J Biol Markers; 2005; 20(4):204-8. PubMed ID: 16398401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer.
    Wang HP; Wang YY; Pan J; Cen R; Cai YK
    World J Gastroenterol; 2014 Feb; 20(5):1332-9. PubMed ID: 24574808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement.
    Chen C; Chen LQ; Yang GL; Li Y
    J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.
    Shinozaki E; Tanabe K; Akiyoshi T; Tsuchida T; Miyazaki Y; Kojima N; Igarashi M; Ueno M; Suenaga M; Mizunuma N; Yamaguchi K; Nakayama K; Iijima S; Yamaguchi T
    BMC Cancer; 2018 Apr; 18(1):406. PubMed ID: 29642865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.
    Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E
    J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients.
    Pochechueva T; Chinarev A; Schoetzau A; Fedier A; Bovin NV; Hacker NF; Jacob F; Heinzelmann-Schwarz V
    PLoS One; 2016; 11(10):e0164230. PubMed ID: 27764122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.